Pharmacological treatment of sleep apnea: current situation and future strategies

Sleep Medicine Reviews
Jan HednerDing Zou

Abstract

Current forms of mechanical treatment in obstructive sleep apnea (OSA) are generally effective in eliminating sleep and breathing disorders. However, they do have drawbacks, such as incomplete tolerability and non-compliance. Several attempts have been made to identify pharmacological treatments for OSA, but no drug has consistently reduced the severity of the condition by more than 50%. OSA, in most cases, is a condition characterized by considerable comorbidity, including hypertension, obesity, metabolic derangement and hormonal dysfunction. Daytime sleepiness and cognitive dysfunction represent common, but not consistent, findings in people with this nocturnal sleep and breathing disorder. Hence, future pharmacological treatments for OSA may need to take aspects other than the nocturnal breathing events alone into consideration. Drug research into OSA has been hampered by the lack of useful experimental systems and animal models for drug screening. In addition, the phenotypic characterization of OSA seems to be incomplete, and this limits the possibility of using stringent criteria for patient selection in drug studies. Finally, the criteria for defining the severity of OSA and disease impact seem to be insufficient for adeq...Continue Reading

References

Feb 1, 1977·The American Journal of Psychiatry·H S SchmidtP R Hyman
Dec 1, 1992·The American Review of Respiratory Disease·D A StewartC E Sullivan
Mar 1, 1992·Chest·E Mulloy, W T McNicholas
Dec 1, 1990·Journal of Cardiovascular Pharmacology·J MayerJ H Peter
Jun 1, 1991·The American Review of Respiratory Disease·H E GreenbergR M Goldring
Dec 1, 1988·The American Journal of Medicine·R R Grunstein, C E Sullivan
Nov 1, 1986·The American Review of Respiratory Disease·A R GoldP L Smith
Jul 1, 1988·The American Review of Respiratory Disease·D W HudgelA Dadley
Oct 1, 1984·Annals of Internal Medicine·K R RajagopalC W Zwillich
Oct 1, 1982·Archives of Internal Medicine·D P WhiteJ V Weil
Mar 1, 1981·The American Journal of Medicine·A J BlockB Cantor
Feb 1, 1995·The European Respiratory Journal·A J FinnimoreR D McEvoy
Jan 1, 1995·American Journal of Respiratory and Critical Care Medicine·W A DeBackerP Van deHeyning
Aug 1, 1994·American Journal of Respiratory and Critical Care Medicine·D G DavilaJ W Shepard
Oct 1, 1994·Annals of Internal Medicine·R R GrunsteinC E Sullivan
Apr 29, 1993·The New England Journal of Medicine·T YoungS Badr
Jun 1, 1993·The American Review of Respiratory Disease·F SérièsJ La Forge
Aug 22, 1996·The New England Journal of Medicine·S JavaheriG A Roselle
Sep 1, 1996·The European Respiratory Journal·B Schönhofer, D Köhler
Nov 1, 1996·Clinical Endocrinology·F RosenowW D Heiss
Jan 1, 1997·Respiration; International Review of Thoracic Diseases·I ArnulfJ P Derenne
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·N M SkjodtP A Easton
Sep 16, 1999·Menopause : the Journal of the North American Menopause Society·D L KeefeF Naftolin
Dec 10, 1999·American Journal of Respiratory and Critical Care Medicine·D W Carley, M Radulovacki
Jun 1, 1995·Journal of Sleep Research·A R SchwartzP L Smith
Mar 16, 2000·The American Journal of Medicine·A J IngA B Breslin
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·J SunderramR J Strobel
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·P J OhtakeD Gozal
Dec 21, 2000·JAMA : the Journal of the American Medical Association·P E PeppardJ Skatrud
May 22, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·O RestaG De Pergola
Jul 4, 2001·American Journal of Epidemiology·A B NewmanUNKNOWN Sleep Heart Health Study Research Group
Nov 14, 2001·Current Opinion in Pulmonary Medicine·R Zozula, R Rosen
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·A I PackJ K Matheson
Dec 6, 2001·The Journal of Pharmacy and Pharmacology·M RadulovackiD W Carley
Jan 22, 2002·The Laryngoscope·B A SeniorM Benninger
Feb 7, 2002·The European Respiratory Journal·T SaaresrantaO Polo

❮ Previous
Next ❯

Citations

Nov 6, 2013·Pharmacology & Therapeutics·M DreslerF Holsboer
Sep 12, 2009·Current Treatment Options in Neurology·Nancy A Collop
Apr 25, 2009·Expert Opinion on Investigational Drugs·Malcolm KohlerJohn R Stradling
May 21, 2013·Respiratory Physiology & Neurobiology·David WangRonald R Grunstein
Sep 4, 2012·European Journal of Internal Medicine·Massimo R MannarinoMatteo Pirro
Dec 7, 2010·Revue des maladies respiratoires·M-F VecchieriniP Lévy
Jan 19, 2008·Sleep Medicine Reviews·Ronald R GrunsteinPeter Y Liu
Oct 15, 2011·Respiration; International Review of Thoracic Diseases·J Richard SkellyKen D O'Halloran
Aug 27, 2011·American Journal of Respiratory Cell and Molecular Biology·J Richard SkellyKen D O'Halloran
Nov 7, 2017·Internal Medicine Journal·Anna MohammadiehPeter A Cistulli
May 25, 2018·Expert Opinion on Pharmacotherapy·Jacek Wolf, Krzysztof Narkiewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Related Papers

Expert Opinion on Pharmacotherapy
Chia Mo LinChristian Guilleminault
American Journal of Respiratory and Critical Care Medicine
Jan HednerPaul Murphy
Expert Opinion on Investigational Drugs
Malcolm KohlerJohn Stradling
Therapeutic Advances in Respiratory Disease
Gnananadh JayaramanAmir Sharafkhaneh
© 2021 Meta ULC. All rights reserved